Most people with herpes never get a clear signal that they carry the virus. Roughly half of all genital herpes shedding days produce no noticeable symptoms, and many who are infected go years or even a lifetime without a recognizable outbreak. That makes the question of “how do you know” genuinely complicated, because the answer depends on whether you have visible symptoms to test, whether you rely on a blood test, and how carefully the results are interpreted.
What a First Outbreak Looks Like
A first episode of genital or oral herpes tends to be the most noticeable. The classic pattern starts with tingling, itching, or burning in a localized area, followed within hours or days by small fluid-filled blisters that break open into shallow, painful sores. These sores crust over and heal, usually within two to three weeks without treatment. During a first outbreak, you may also feel generally unwell. In a study of people with cold sores (oral herpes), the most commonly reported body-wide symptoms were malaise, reported by about half of participants, and fever at a similar rate, followed by headache, muscle aches, and swollen lymph nodes.1PubMed Central. From a focal skin issue to a systemic disease: the multifaceted nature of cold sores, novel findings Genital herpes first episodes can produce the same flu-like symptoms, and tender swollen lymph nodes in the groin are a particularly common accompaniment.
That textbook description is useful, but relying on it alone can lead you astray. The severity of a first outbreak varies enormously from person to person. Some people develop dozens of painful sores that make walking or urinating difficult. Others get one or two spots they barely notice or mistake for an ingrown hair, a yeast infection, or a skin irritation. The virus type matters here: a first genital episode caused by HSV-1 tends to produce symptoms similar to HSV-2 initially, but recurrences behave quite differently, as we will see below.
When Symptoms Don’t Look Typical
One of the biggest reasons herpes goes unrecognized is that a large share of cases simply don’t look like the textbook photos. In a study of 170 patients with confirmed genital herpes, about half presented with either lesions in unexpected locations or with morphologically atypical forms. The most common “wrong” location was the buttocks, seen in about one in five patients, followed by the thigh, anal region, and even the fingers. Among those with atypical-looking lesions, presentations included a single ulcer, an erosion, a crust, a fissure, or just redness and swelling rather than the cluster of blisters people expect.2Dermatology. The Heterogeneous Clinical Spectrum of Genital Herpes
This means that if you are waiting for a clear cluster of blisters on your genitals before suspecting herpes, you could easily miss the diagnosis. A recurring sore on the buttock, a crack near the anus, or persistent redness you’ve been treating as a fungal infection could all be herpes in disguise. Any unexplained, recurring sore or irritation in the genital or surrounding area is worth getting swabbed, especially if it comes and goes in a pattern.
Recurrent Outbreaks and How They Differ
After the first episode, the virus retreats into nerve cells near the spine, where it lies dormant until something triggers it to reactivate. Recurrences are usually milder and shorter than the initial outbreak. Many people notice a prodrome, a warning phase of tingling, burning, or itching at the site for a few hours to a couple of days before sores appear. The lesions themselves tend to be smaller, fewer in number, and heal faster.
How often recurrences happen depends heavily on which virus type you carry and where. A study from Valencia, Spain, found that recurrent genital herpes occurred in about 40% of people with HSV-2 but only 13% of those with HSV-1.3PubMed. Genital Infection With Herpes Simplex Virus Type 1 and Type 2 in Valencia, Spain: A Retrospective Observational Study This is one of the most important practical differences between the two types when they infect the genitals. HSV-1 genital infections tend to quiet down after the first year, while HSV-2 genital infections can recur multiple times a year for many years, though the frequency typically declines over time.
If you start early antiviral treatment during a recurrence, you can shorten the episode. A randomized trial found that a single day of famciclovir cut healing time and symptom duration by roughly two days compared to placebo, and prevented progression to a full outbreak in nearly one in four patients.4PubMed Central. Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes Starting treatment during the prodrome, before blisters form, gives the best results.
Asymptomatic Infection and Silent Shedding
Here is where herpes gets genuinely tricky: the virus can reactivate and appear on the skin surface without producing any visible sores or sensations you’d notice. This is called asymptomatic or subclinical shedding, and it is the main way herpes spreads between sexual partners.5PubMed Central. Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding
A large study comparing people who knew they had genital herpes (symptomatic) with those who had HSV-2 antibodies but had never had a recognized outbreak (asymptomatic) found that both groups shed virus subclinically. Among those with recognized symptoms, about 57% of all shedding days were subclinical, meaning even people who get outbreaks are shedding without realizing it more often than not. Among those with no history of outbreaks, a striking 84% of shedding days were subclinical. The amount of virus detected during those silent episodes was essentially the same in both groups.6JAMA. Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection In practical terms, a person who has never had a visible outbreak can still pass the virus to a partner, and the viral load during those hidden episodes is comparable to what someone with obvious sores would shed between outbreaks.
This reality is what makes testing so important. You cannot rule out herpes just because you’ve never had symptoms.
Swab Testing During an Active Outbreak
If you have a visible sore, blister, or suspicious lesion, the gold-standard approach is to have it swabbed and tested directly. The swab picks up actual viral material from the lesion, which means a positive result confirms not just that you have herpes but which type (HSV-1 or HSV-2) you carry at that site.
There are two main laboratory methods used on swab specimens. Viral culture, the older technique, grows the virus from the sample in a lab. PCR (polymerase chain reaction) detects viral DNA directly and is substantially more sensitive. In a comparison of over 36,000 mucosal samples from people with HSV, culture detected virus in 3% of specimens while PCR detected viral DNA in about 12%, roughly four times the pickup rate.7The Journal of Infectious Diseases. Polymerase Chain Reaction for Detection of Herpes Simplex Virus (HSV) DNA on Mucosal Surfaces: Comparison with HSV Isolation in Cell Culture A head-to-head comparison of PCR and culture on neonatal swab specimens found PCR had 100% sensitivity compared to 50% for culture, with no false positives from either method.8PubMed Central. Comparison of Herpes Simplex Virus PCR with Culture for Virus Detection in Multisource Surface Swab Specimens from Neonates
Timing matters enormously for swab testing. Virus levels in lesions peak during the first 24 hours and drop off rapidly after that. A classic study of recurrent cold sores found that virus-positive swabs hit 89% on day one and decreased steadily as the sore progressed through crusting and healing.9PubMed. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy So if you suspect a herpes sore, get it swabbed as early as possible, ideally while the lesion is still fresh, wet, or blistered. A crusted-over sore may yield a false negative simply because there isn’t enough virus left on the surface to detect. Even with PCR, a swab taken too late may come back negative despite the lesion being herpes.
If your clinic still uses culture rather than PCR, be aware that a negative culture is less reassuring. Many clinics have shifted to PCR, but it’s worth asking which test is being run, especially if your swab comes back negative despite a suspicious-looking lesion.
Blood Tests and Their Limitations
When there’s no active lesion to swab, or when you want to know your herpes status in general, the option is a blood test that looks for antibodies, proteins your immune system produces after being exposed to the virus. These are called type-specific IgG antibody tests, and they can distinguish between HSV-1 and HSV-2. Unlike swab tests, blood tests don’t tell you where in the body the infection lives. A positive HSV-1 IgG result, for example, could mean oral herpes, genital herpes, or herpes at another site. A positive HSV-2 IgG result almost always indicates genital infection, since HSV-2 rarely establishes itself elsewhere.
The trouble is that the most widely used commercial blood tests have a real false-positive problem, particularly at low index values. In a study evaluating three automated HSV IgG assays, the DiaSorin platform produced false-positive HSV-1 results in about 61% of samples with low-positive index values (below 3.0), and false-positive HSV-2 results in about 21% of low-positive samples. When the researchers factored in the estimated 12% prevalence of HSV-2 in the United States, the positive predictive value for DiaSorin HSV-2 IgG was just 69%, meaning roughly one in three positive results would be wrong.10PubMed Central. Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing The Roche platform performed better, with a positive predictive value of about 96% for HSV-2, and the Bio-Rad HerpeSelect fell in between at around 87%.
A separate study looking specifically at the DiaSorin assay found that of over 2,300 consecutive HSV-2 positive samples, about 18% were negative on the HerpeSelect assay, and most of those discordant results fell in the low-positive index range.11Sexually Transmitted Diseases. Characterization of Serum Samples With Discordant Results in 2 Herpes Simplex Virus Type 2 IgG Assays Confirmatory testing of low-positive results is critical, but even the practice of only confirming low-positive samples isn’t foolproof. Research has shown that a meaningful portion of false-positive sera can have index values above the commonly used 3.5 cutoff, which means some false positives slip through even when the standard confirmation guidelines are followed.12Diagnostic Microbiology and Infectious Disease. Herpes simplex virus type 2 (HSV-2) IgG index values in two immunoassays in relation to HSV-2 IgG inhibition assay results
Practically, if you get a blood test for HSV-2 and the result is positive with a low index value, you should request confirmatory testing before accepting the diagnosis. If your provider isn’t familiar with this issue, asking specifically about the index value and whether a supplemental test (such as the University of Washington Western blot or an inhibition assay) is available can save you from a misdiagnosis that carries real emotional weight.
Why Routine Screening Isn’t Recommended for Most People
Given the prevalence of herpes and the frequency of asymptomatic infection, you might assume that screening everyone would be a good idea. The U.S. Preventive Services Task Force disagrees. In their recommendation statement, the USPSTF concluded that the harms of population-based serologic screening for genital herpes in people without symptoms outweigh the benefits. Their reasoning centers on the high false-positive rate of the most widely used commercial tests, the lack of widely available confirmatory testing, and the psychological harm a false or ambiguous diagnosis can cause, including anxiety and disruption of personal relationships.13JAMA. Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement
This does not mean testing is never appropriate. The USPSTF recommendation applies to screening asymptomatic people who have no particular reason to suspect infection. If you have symptoms, a known exposure, a partner with herpes, or specific risk factors, testing is a different conversation. The issue is with mass screening using tests that generate too many false positives in a population where most positive results at low index values won’t hold up on confirmatory testing.
The Shift From HSV-2 to HSV-1 in Genital Herpes
For decades, genital herpes was nearly synonymous with HSV-2. That picture has changed. In many high-income countries, HSV-1 has become the leading cause of first-episode genital herpes, particularly among adolescents and young adults. HSV-1 genital infections are rising by an estimated 1-2% annually in many areas.14PubMed. From HSV-2 to HSV-1: A change in the epidemiology of genital herpes The shift appears to be driven by declining rates of childhood oral HSV-1 exposure, meaning more people reach sexual debut without existing immunity, and by changes in sexual practices including oral sex.
This matters for diagnosis because knowing your virus type changes your prognosis. HSV-1 genital infections recur far less frequently than HSV-2, as noted earlier. Someone told they have “genital herpes” without type-specific testing might assume they face frequent lifelong recurrences when their actual outlook could be much milder. Always ask for type-specific results, whether from a swab or a blood test.
The geographic pattern is not uniform. In Africa, Latin America, and Southeast Asia, HSV-2 remains the dominant cause of genital herpes, and the epidemiological shift toward HSV-1 is occurring more slowly.14PubMed. From HSV-2 to HSV-1: A change in the epidemiology of genital herpes
Self-Collected Swabs
If the idea of going to a clinic to get a genital sore swabbed feels like a barrier, there’s good news. Research consistently shows that self-collected genital swabs perform well for detecting HSV. A validation study found high rates of adequate DNA recovery from self-collected specimens, suggesting thorough sampling even without clinical training.15PubMed Central. High rate of β-globin DNA detection validates self-sampling in HSV shedding studies In a direct comparison, self-collected genital swabs actually detected HSV-2 more frequently than clinician-collected cervicovaginal lavage samples, and the two methods were well correlated and equally able to detect the virus-suppressive effect of antiviral medication.16PubMed Central. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding A broader systematic review and meta-analysis of self-collected versus healthcare-worker-collected specimens across multiple sexually transmitted infections found comparable diagnostic accuracy.17Scientific Reports. Accuracy of self-collected versus healthcare worker collected specimens for diagnosing sexually transmitted infections in females: an updated systematic review and meta-analysis
Some at-home STI testing services now offer mail-in swab kits for active lesions, though availability varies by country and region. If you do use a home kit, the same timing advice applies: swab the lesion while it’s fresh, not after it has crusted over.
Antivirals and What They Do for Shedding
Antiviral medications don’t cure herpes, but they substantially reduce how often the virus shows up on the skin surface. Daily suppressive therapy with valacyclovir cut genital shedding days from about 11% to about 3% compared with placebo, and reduced the monthly recurrence rate from 0.40 to 0.11.18PubMed. Once-daily valacyclovir to reduce the risk of transmission of genital herpes Acyclovir, the older drug in the same class, showed a 94% reduction in subclinical shedding in a crossover trial of women with HSV-2.19PubMed. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir
The newer drug pritelivir, which works through a different mechanism, has shown even greater suppression. In a randomized trial, pritelivir reduced genital HSV detection to 2.4% of swab days compared with 5.3% on valacyclovir, and subclinical shedding specifically was cut to 1.8% versus 4.1%.20JAMA. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial Pritelivir is not yet widely available but represents a potential future option, particularly for people who still experience frequent shedding on standard antivirals.
The reason shedding reduction matters beyond symptom control is transmission risk. Since most herpes transmission occurs during asymptomatic shedding, taking a daily antiviral is one of the most effective tools available for reducing the chance of passing the virus to a partner, alongside condom use.
Herpes in Pregnancy
The stakes of herpes diagnosis rise considerably during pregnancy because of the risk of neonatal herpes, a rare but serious infection passed to the baby during delivery. Women who acquire a new genital herpes infection during pregnancy carry a much higher risk of transmitting it than women who had herpes before becoming pregnant.21PubMed Central. Mother-to-Child Transmission of Herpes Simplex Virus In a landmark study, neonatal herpes developed in about a third of babies born to women experiencing their first episode of genital HSV at delivery, compared with about 3% of babies born to women with a recurrence.22PubMed. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor
That difference is largely immunological. A woman with an established infection has already produced antibodies that cross the placenta and provide some protection to the baby, and her viral shedding during delivery tends to be lower. A new infection means high viral load and no pre-existing antibody buffer. Current obstetric practice typically includes suppressive antiviral therapy starting around 36 weeks for women with known genital herpes, and cesarean delivery is recommended if active lesions are present at the onset of labor.
Because many women don’t know they carry HSV, neonatal herpes cases sometimes occur in pregnancies where the mother was never diagnosed. If you are pregnant and your partner has a history of herpes but you don’t, that information is worth sharing with your obstetrician so that preventive strategies can be discussed.
The Emotional Weight of a Diagnosis
For many people, the emotional reaction to a herpes diagnosis is worse than the physical symptoms. The stigma around herpes is disproportionate to its medical severity, and receiving a positive result, especially an unexpected one from a blood test, can trigger anxiety about relationships, self-worth, and disclosure. Research on the psychological impact of asymptomatic HSV-2 diagnosis found that the diagnosis did not cause lasting psychological difficulties for most people. Those who were most affected tended to be interpersonally vulnerable before the diagnosis, suggesting that existing emotional patterns amplify the impact rather than the diagnosis itself being uniquely damaging.23Sexually Transmitted Infections. The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection
This finding underscores why the USPSTF worries about screening everyone: giving someone a positive result, particularly a false positive or a low-confidence positive, when they’ve never had symptoms can cause real psychological harm without a clear medical benefit. If you do receive a positive blood test, understanding the nuances covered above (index values, false-positive rates, the need for confirmatory testing) can help you avoid spiraling over a result that may not even be accurate. And if the result is confirmed, knowing that the virus is extremely common, that effective treatments exist, and that most people with herpes live completely normal lives is not just reassurance but a factual description of the medical landscape.